Celecoxib in Treating Patients With Early-Stage Rectal Cancer
Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of tissue, blood, and urine from patients with cancer in the
laboratory may help doctors learn more about changes that may occur in DNA and identify
biomarkers related to cancer. It may also help doctors predict how rectal cancer will respond
to treatment with celecoxib.
PURPOSE: This clinical trial is studying how well celecoxib works in treating patients with
early-stage rectal cancer.